1. Home
  2. TIL vs VFL Comparison

TIL vs VFL Comparison

Compare TIL & VFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIL
  • VFL
  • Stock Information
  • Founded
  • TIL 2018
  • VFL 1993
  • Country
  • TIL United States
  • VFL United States
  • Employees
  • TIL N/A
  • VFL N/A
  • Industry
  • TIL Biotechnology: Pharmaceutical Preparations
  • VFL Finance/Investors Services
  • Sector
  • TIL Health Care
  • VFL Finance
  • Exchange
  • TIL Nasdaq
  • VFL Nasdaq
  • Market Cap
  • TIL 134.5M
  • VFL 125.2M
  • IPO Year
  • TIL 2021
  • VFL N/A
  • Fundamental
  • Price
  • TIL $20.97
  • VFL $10.38
  • Analyst Decision
  • TIL Strong Buy
  • VFL
  • Analyst Count
  • TIL 4
  • VFL 0
  • Target Price
  • TIL $114.00
  • VFL N/A
  • AVG Volume (30 Days)
  • TIL 103.6K
  • VFL 38.0K
  • Earning Date
  • TIL 11-13-2024
  • VFL 01-01-0001
  • Dividend Yield
  • TIL N/A
  • VFL 4.16%
  • EPS Growth
  • TIL N/A
  • VFL N/A
  • EPS
  • TIL N/A
  • VFL N/A
  • Revenue
  • TIL N/A
  • VFL N/A
  • Revenue This Year
  • TIL N/A
  • VFL N/A
  • Revenue Next Year
  • TIL $2.65
  • VFL N/A
  • P/E Ratio
  • TIL N/A
  • VFL N/A
  • Revenue Growth
  • TIL N/A
  • VFL N/A
  • 52 Week Low
  • TIL $9.20
  • VFL $7.93
  • 52 Week High
  • TIL $92.00
  • VFL $10.77
  • Technical
  • Relative Strength Index (RSI)
  • TIL 46.36
  • VFL 52.38
  • Support Level
  • TIL $18.56
  • VFL $10.03
  • Resistance Level
  • TIL $22.00
  • VFL $10.28
  • Average True Range (ATR)
  • TIL 1.98
  • VFL 0.10
  • MACD
  • TIL 0.36
  • VFL 0.04
  • Stochastic Oscillator
  • TIL 28.05
  • VFL 86.67

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

About VFL abrdn National Municipal Income Fund

Delaware Investments Natl Muni Income is a closed-end investment fund. The Fund seeks to provide current income exempt from regular federal income tax consistent with the preservation of capital. The company's product portfolio includes Mutual funds, Exchange-traded funds, Private markets, Delaware Funds by Macquarie Premier Models, Managed accounts, Closed-end funds, and Variable Insurance Products.

Share on Social Networks: